138 related articles for article (PubMed ID: 38138858)
1. CD24 in Head and Neck Malignancies-An Uprising Biomarker?
Carmel Neiderman NN; Shapira S; Klein L; Rafael D; Gorelik G; Kampel L; Arber N; Muhanna N
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138858
[TBL] [Abstract][Full Text] [Related]
2. Predictors of the CD24/CD11b Biomarker among Healthy Subjects.
Shapira S; Aiger G; Ohayon A; Kazanov D; Mdah F; Shimon MB; Hay-Levy M; Banon L; Laskov I; Mashiah J; Lev-Ari S; Arber N
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575716
[TBL] [Abstract][Full Text] [Related]
3. Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies.
Shapira S; Kazanov D; Mdah F; Yaakobi H; Herishanu Y; Perry C; Avivi I; Itchaki G; Shacham-Abulafia A; Raanani P; Hay-Levy M; Aiger G; Mashiah J; Lev-Ari S; Arber N
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442367
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CD24 in nonmelanoma skin cancer.
Miller E; Shapira S; Gur E; Naumov I; Kazanov D; Leshem D; Barnea Y; Meshiach Y; Gat A; Sion D; Arber N; Kraus S
Int J Biol Markers; 2012 Dec; 27(4):e331-6. PubMed ID: 23250778
[TBL] [Abstract][Full Text] [Related]
5. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
7. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
9. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.
Tanaka T; Terai Y; Kogata Y; Ashihara K; Maeda K; Fujiwara S; Yoo S; Tanaka Y; Tsunetoh S; Sasaki H; Kanemura M; Tanabe A; Ohmichi M
Oncol Rep; 2015 Nov; 34(5):2282-8. PubMed ID: 26351781
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
11. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD24 as Cancer Stem Cell Marker in the Diagnosis of Oral Squamous Cell Carcinoma - A Prospective Study.
Muralidoss H; Muthusekhar MR
Ann Maxillofac Surg; 2023; 13(1):26-30. PubMed ID: 37711538
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44
Sihombing UHM; Andrijono ; Purwoto G; Gandamihardja S; Harahap AR; Rustamadji P; Kekalih A; Widyawati R; Fuady DR
Gynecol Oncol Rep; 2022 Aug; 42():101005. PubMed ID: 35707599
[TBL] [Abstract][Full Text] [Related]
14. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
15. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
16. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
[No Abstract] [Full Text] [Related]
17. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.
Zheng J; Li Y; Yang J; Liu Q; Shi M; Zhang R; Shi H; Ren Q; Ma J; Guo H; Tao Y; Xue Y; Jiang N; Yao L; Liu W
BMC Cancer; 2011 Jun; 11():251:1-9. PubMed ID: 21676268
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma.
Han J; Kioi M; Chu WS; Kasperbauer JL; Strome SE; Puri RK
Head Neck Oncol; 2009 Jul; 1():27. PubMed ID: 19602232
[TBL] [Abstract][Full Text] [Related]
19. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
20. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.
Bektas S; Bahadir B; Ucan BH; Ozdamar SO
Pathol Oncol Res; 2010 Dec; 16(4):569-77. PubMed ID: 20177845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
